Gene Transfer of Calcium-Binding Proteins into Adult Cardiac Myocytes

Brian R Thompson1, Houda Cohen1, Addeli Bez Batti Angulski1

  • 1Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.

Insights

Researchers explored using parvalbumin gene transfer to improve calcium handling in heart failure. This therapeutic approach aims to restore normal heart muscle function by enhancing calcium buffering in cardiac myocytes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Heart failure is a leading cause of death, with diastolic heart failure comprising 50% of cases.
  • Diastolic heart failure is characterized by impaired myocardial relaxation and left ventricular filling.
  • Calcium-handling dysregulation is a key factor contributing to diastolic heart failure.

Purpose of the Study:

  • To investigate novel human calcium (Ca2+) binding protein motifs for restoring normal Ca2+ handling in diseased myocardium.
  • To evaluate gene transfer of parvalbumin as a potential therapeutic strategy for diastolic heart failure.
  • To provide protocols for studying parvalbumin function in adult cardiac myocytes.

Main Methods:

  • Utilizing gene transfer of parvalbumin into adult cardiac myocytes.
  • Employing acute adenoviral gene transfer to deliver parvalbumin.
  • Studying wild-type parvalbumin isoforms and engineered parvalbumins with specific EF-hand motifs.

Main Results:

  • Parvalbumin acts as a strategic Ca2+ buffer to correct cardiac mechanical dysfunction.
  • Adenoviral gene transfer protocols were established for studying parvalbumin in cardiac myocytes.
  • Optimization of parvalbumin function for therapeutic applications in heart failure was pursued.

Conclusions:

  • Gene transfer of parvalbumin shows potential as a therapeutic for heart failure by addressing calcium-handling deficits.
  • Engineered parvalbumin motifs may offer enhanced therapeutic benefits.
  • The described protocols facilitate the development of parvalbumin-based therapies for failing heart muscle.

Related Concept Videos

Horizontal Gene Transfer01:27

Horizontal Gene Transfer

Horizontal gene transfer (HGT) is a process where genetic material moves between organisms within the same generation, unlike vertical gene transfer, which occurs from parent to offspring. HGT plays a crucial role in microbial evolution, adaptation, and survival, particularly in shared environments like the human gut.Mobile genetic elements such as plasmids, prophages, integrons, insertion sequences, and transposons facilitate this process. HGT occurs through three primary mechanisms:...
2.0K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.5K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

4.5K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
554
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K